4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-24-030005
VP, Clinical Trial Operations acquired 29,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-18 | Grant or award : show line 1 in the form | +29,000 | 39,869 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-18 | Grant or award : show line 2 in the form Stock Option (right to buy) | +39,000 | 39,000 | D |
Loading xslF345X05/form4-12212024_011230.xml…